来自血的缩生长因子注射用于治疗较大的慢性下肢缺陷
Zhiqiang Zhang1,2, Nan Cao1,2, Chaoqi Zuo1,2
1Dermatology Hospital of Shandong First Medical University, Jinan, Shandong, China.
Frontiers in bioengineering and biotechnology
|December 15, 2025
概括
自主血注射的缩生长因子有效治疗慢性下肢,促进伤口愈合和减少复发. 需要进一步的研究来证实这些有前途的发现在更大的患者队列.
科学领域:
- 再生医学是一种再生医学.
- 伤口愈合生物学 伤口愈合生物学
背景情况:
- 慢性下肢是一个重大的临床挑战,复发率很高.
- 在慢性伤口中,由于持续的炎症和细胞信号的改变,伤口愈合受损.
- 增长因子 (GF) 对于组织修复至关重要,但它们在慢性伤口中的有效性受到受体下调的限制.
研究的目的:
- 评估缩自主生长因子在治疗慢性下肢的疗效.
- 评估血衍生生长因子注射对伤口愈合参数的影响.
- 调查这种再生方法在改善结局的潜力.
主要方法:
- 五名患有慢性下肢的患者每周接受来自自身血的缩生长因子注射.
- 每次注射后,都会对伤口的状况进行监测,包括伤口的大小,脂质皮质硬化和颜色.
- 治疗涉及总共五次注射,在五周内进行.
主要成果:
- 在治疗两周后,观察到伤口面积显著减少.
- 在脂质皮质硬化和异常色素的明显改善.
- 在所有接受治疗的患者中实现了完整的伤口上皮质化.
结论:
- 缩自主生长因子的注射显示出作为慢性下肢的有效治疗的潜力.
- 这种再生疗法可以通过促进伤口关闭来克服传统治疗的局限性.
- 需要使用更大的样本大小进行进一步的研究,以验证这些发现并最大限度地减少偏见.
更多相关视频
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
3.6K
14:49Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration
Published on: September 29, 2018
42.4K
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
01:19Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K